AC-0176

N/A

Report date: 2025/02/25 20:00:09
NME

Base Information

Drug NameAC-0176
Drug Alias NameAC-0176AC-176AC0176AC176
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesAccutar Biotechnology Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms, Castration-Resistant

Other Information

ATC CodeN/A
Related LinksN/A